A study published in Human Reproduction Open suggests a potential link between prenatal paracetamol exposure and minor changes in ovarian volume in female infants.
Experts caution that the study is not a randomized controlled trial and that the findings may be due to chance or residual confounding factors.
Medical professionals emphasize that paracetamol maintains a high safety profile and advise that pregnant women should not alter their pain management based on these exploratory results.